Accuracy of Hemoglobin E Screening Test Using Allelic Discrimination Assay

Main Article Content

Supranee Upanan
Somdet Srichairatanakool
Sirivipa Piyamongkol
Wirawit Piyamongkol

Abstract

Objectives:  To determine the accuracy of allelic discrimination (AD) assay for hemoglobin E (Hb E) screening test in Chiang Mai Strategy for thalassemia prevention and control.
Materials and Methods:  This study evaluated the AD assay compared with conventional Hb E screening tests used in Chiang Mai Strategy of Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand. In this assay, two TaqMan probes were designed to discriminate heterozygous and homozygous by detecting normal and mutant nucleotides of Hb E gene.
Results:  From 55 blinded DNA samples, the AD assay revealed the results with 100% sensitivity, specificity, positive predictive value, negative predictive value and efficiency when compared to the conventional Hb E screening tests of the Chiang Mai Strategy.
Conclusion:  The AD assay is effective as an Hb E screening test in the thalassaemia prevention and control program. Moreover, AD assay can distinguish heterozygous from homozygous genotypes.

Downloads

Download data is not yet available.

Article Details

Section
Original Article

References

1. Kor-anantakul O, Suwanrath CT, Leetanaporn R, Suntharasaj T, Liabsuetrakul T, Rattanaprueksachart R. Prenatal diagnosis of thalassemia in Songklanagarind Hospital in southern Thailand. Southeast Asian J Trop Med Public Health 1998;29:795-800.
2. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11:65-88.
3. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001;79:704-12.
4. Tongsong T, Wanapirak C, Sirivatanapa P, Sanguansermsri T, Sirichotiyakul S, Piyamongkol W, et al. Prenatal control of severe thalassaemia: Chiang Mai strategy. Prenat Diagn 2000;20:229-34.
5. Fucharoen S, Winichagoon P, Wisedpanichkij R, Sae-Ngow B, Sriphanich R, Oncoung W, et al. Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. Clin Chem 1998;44: 740-8.
6. Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ 2004;82: 364-72.
7. Sirichotiyakul S, Tongprasert F, Tongsong T. Screening for hemoglobin E trait in pregnant women. Int J Gynaecol Obstet 2004;86:390-1.
8. Wanapirak C, Sirichotiyakul S, Luewan S, Srisupundit K, Tongsong T. Comparison of the accuracy of dichlorophenolindophenol (DCIP), modified DCIP, and hemoglobin E tests to screen for the HbE trait in pregnant women. Int J Gynaecol Obstet 2009;107: 59-60.
9. Kho SL, Chua KH, George E, Tan JA. High throughput molecular confirmation of beta-thalassemia mutations using novel TaqMan probes. Sensors (Basel) 2013;13:2506-14.
10. Wiwanitkit V. A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women. Arch Gynecol Obstet 2006;274:88-90.
11. Winichagoon P, Svasti S, Munkongdee T, Chaiya W, Boonmongkol P, Chantrakul N, et al. Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. Transl Res 2008;152:178-84.
12. Tongsong T, Sirichotiyakul S, Chaisen R, Wanapirak C. Sensitivity and specificity of dichlorophenol--indophenol precipitation test to screen for the hemoglobin E trait in pregnant women. Int J Gynaecol Obstet 2006;95: 149-50.
13. Chapple L, Harris A, Phelan L, Bain BJ. Reassessment of a simple chemical method using DCIP for screening for haemoglobin E. J Clin Pathol 2006;59:74-6.